drugset / Trial / NCT00690274
Study to Demonstrate Cognitive Enhancing Effects of BF2.649
Phase 2
Completed
52 enrolled
University of Texas Southwestern Medical Center
Bioprojet · collabStanley Medical Research Institute · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the cognitive enhancing effect of BF2.649 and to evaluate the effect of BF2.649 on symptom severity in persons with schizophrenia or schizoaffective disorder.
Timeline
- Start
- 2008-06
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pitolisant | Small molecule | 20 mg | — |